<unk> , sold under the brand names Edurant and Rekambys, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.
Rilpivirine
Remdesivir
Letermovir
Saquinavir
Entecavir
Amprenavir
Ritonavir
Coronavir